Acute sepsis profoundly changes how intravenous fluids behave within the body. Using a sheep model, researchers investigated ...
MedPage Today on MSN
Race for the Rheum Disease Cure Heats Up
For starters, she pointed out that standard CAR-T therapy involves a lymphodepletion regimen with cyclophosphamide and ...
靶标发现领域的"Cell级"突破在生命科学研究中,Cell期刊始终代表着领域内的最高水平和前沿方向。2023-2025年,靶标发现领域迎来了多项突破性进展,从机器学习驱动的大规模抗菌肽挖掘到精准的蛋白质组动态分析,从新型抗生素开发到癌症免疫治疗靶标鉴 ...
Under normal conditions, cytokines aid in pathogen recognition and elimination while contributing to immune system ...
The US FDA approved 46 new drugs in 2025, despite a tumultuous year at the regulatory agency.
An evidence-based exploration of how culinary botanicals synergize with cannabinoids to create pharmacologically active, ...
The AMD market is expected to grow at a CAGR of 10.2% over the course of the forecast period (2024–34), reaching $20.5bn ...
January 5, 2026 Citrus Burn is a citrus-derived dietary supplement formulated to support metabolism, daily energy levels, and ...
Techno-Science.net on MSN
Effective diabetes medications to fight cancer
Could diabetes medications have an influence beyond simply regulating blood sugar? This question is gaining ground in ...
FD4 to XingImaging and to ABLi Therapeutics to evaluate alpha-synuclein clearance from the brain in response to ...
Morning Overview on MSN
New method could mass-produce cancer-fighting natural killer cells
Cancer immunotherapy has been transformed by engineered T cells, but those bespoke treatments are slow, expensive, and out of ...
SynuSight Biotech has licensed 18 F-FD4 to XingImaging and to ABLi Therapeutics to evaluate alpha-synuclein clearance from the brain in response to risvodetinib treatment . SHANGH ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果